OS Therapies Incorporated vs Ovid Therapeutics Inc. — Valuation Comparison 2026
Access all valuation models for OSTX vs OVID — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.
Access Full Analysis — From $27/mo →OVID scores higher with a 5.3/10 quality rating vs OSTX's 3.1/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.
Comparing OS Therapies Incorporated (OSTX) and Ovid Therapeutics Inc. (OVID) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.
OSTX currently trades at $2.14 with a QOC of 3.1/10, while OVID trades at $2.73 with a QOC of 5.3/10.
Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).